| For: | Li HD, Liu YN, Wu S, Quan XF, Wang XY, Xiang TD, Li SM, Xu L, Wang T, Wang H, Zheng X. Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus. World J Hepatol 2024; 16(12): 1395-1406 [PMID: 39744194 DOI: 10.4254/wjh.v16.i12.1395] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i12/1395.htm |
| Number | Citing Articles |
| 1 |
Abdullah M. Al-Alawi, Amna S. Al-Balushi, Halima H. Al-Shuaili, Dalia A. Mahmood, Said A. Al-Busafi. Application of Machine Learning Models in Predicting Non-Alcoholic Fatty Liver Disease Among Inactive Chronic Hepatitis B Patients: A Cross-Sectional Analysis. Journal of Clinical Medicine 2025; 14(14): 5042 doi: 10.3390/jcm14145042
|
| 2 |
Bingqing Wang, Tian Zeng, Wen Yin, Chengrui Ren, Yuting Chen, Liqin Qian, Peng Huang, Chuanlong Zhu, Ming Yue. Unveiling low level viremia in chronic hepatitis B: challenges and new horizons. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1663858
|
